Nabiximols: Multiple Sclerosis
Commons · Question 27239 · Tabled 4 Sep 2026 · Department of Health and Social Care · Official record
Answered 11 Sep 2026
Question
Asked by Yasmin Qureshi
To ask the Secretary of State for Health and Social Care, how many patients with multiple sclerosis were prescribed nabiximols on the NHS in England in each of the last three years by integrated care board.
Answer
Answered by James Frith, 11 Sep 2026
Nabiximols is the United States Adopted Name for the medication marketed as Sativex (dronabinol/cannabidiol) and licensed by the Medicines and Healthcare products Regulatory Agency for symptom improvement in adult patients with moderate to severe spastici...